CEACAM5 and lung adenocarcinoma: Our study provides a nomogram model based on CEA and CYFRA21‐1 as a convenient tool for individualized prediction of the concordance of plasma and tumor biopsies, to optimize the utility of plasma biopsy in genotyping for advanced lung adenocarcinoma patients.